Chekesha S. Clingman
United States Food and Drug Administration(US)Center for Drug Evaluation and Research(US)
Publications by Year
Research Areas
Advanced MRI Techniques and Applications, Advanced Neuroimaging Techniques and Applications, Atomic and Subatomic Physics Research, Electron Spin Resonance Studies, Nanoparticle-Based Drug Delivery
Most-Cited Works
- → Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla(2004)680 cited
- → Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T(2007)247 cited
- → Comparison of the dependence of blood R2 and R on oxygen saturation at 1.5 and 4.7 Tesla(2002)219 cited
- → Measurement of tissue oxygen extraction ratios from venous blood T2: Increased precision and validation of principle(2001)117 cited
- → Evidence-based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTION(2010)83 cited
- → Catalyzing the critical path initiative: FDA's progress in drug development activities(2015)36 cited
- → Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells(2015)17 cited
- → Blood NMR relaxation in the rotating frame: mechanistic implications(2002)11 cited
- → FDA Experience With Regulation of Naloxone Products to Address the Opioid Crisis and Opportunities for Leveraging Scientific Engagement(2020)7 cited